The firm’s GeneReader next-generation sequencing (NGS) System is supported by GeneRead Link, a middleware co-developed by the two companies.
They said it will simplify management of the sequencing information from sample processing to final reports with connectivity into most LIMS systems.
Jonathan Arnold, senior director of marketing NGS at Qiagen, said the value of next-generation sequencing comes from the insights a lab generates.
“Offering GeneReader NGS customers access to Genohm’s proprietary SLims solution, an easy-to-use LIMS and electronic laboratory notebook system, broadens the solution to manage the whole laboratory’s data.”
GeneReader NGS System customers who do not have LIMS can connect to Genohm’s proprietary SLims to help manage data across the laboratory.
Both companies will adapt the middleware as required to support future GeneReader workflows.
Frederik Decouttere, CEO of Genohm, said working with Qiagen enables it to reach more customers around the globe, particularly clinical research and diagnostic labs deploying NGS.
“SLims is a flexible, feature complete, compliant and easy-to-use solution consisting of a LIMS and an Electronic Laboratory Notebook (ELN) that automates interfaces, integrating information flow from every machine in a laboratory, from initial sample shipment to final reporting of results.
“By reducing administrative time, SLims frees staff members to devote themselves to unlocking insights that improve outcomes.”
The GeneReader NGS System, launched in late 2015, is a sample to insight workflow that provides a way for clinical testing laboratories to take advantage of NGS technology.